Cardio3 BioSciences Announces the Nomination of Three Co-principal...

C-CureA is currently in a Phase III clinical trial in . The CHART-2 Phase III trial is a prospective, multi-centre, randomized, sham-controlled, patient- and evaluator-blinded study comparing treatment with C-CureA to a sham treatment.

http://ift.tt/1uVDOYA